SOURCE: BIO-key International, Inc.
WALL, NJ--(Marketwire - Sep 17, 2012) - BIO-key International, Inc. (OTCBB: BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that the company will be presenting the latest advances in fingerprint biometric authentication technology for government, enterprise and consumer markets at the Biometric Consortium Conference at the Tampa - Florida Convention Center (BOOTH # 523) September 18th - 20th.
The Biometric Consortium serves as a focal point for research, development, testing, evaluation and application of biometric-based personal identification/verification technology. The conference presents a forum for biometric technology companies to showcase their latest advancements.
Since the last BCC event in 2011, BIO-key has achieved several notable accomplishments. One such example is offered in a case study conducted with a top U.S. hospital. The study showed that BIO-key technology vastly improved the efficiency of the log-in and two-factor authentication process for staff members using EMR / EHR and ePrescriptions. During a thirty day period staff members logged-in over 252,000 times with a 99.34% initial acceptance rate.
The company also announced the first deployment of BIO-key's WEB-key® finger identification solution for the B.C. Department of Corrections. Sierra Systems, the lead technology partner, is implementing BIO-key's custom authentication scheme for CA Technologies "SiteMinder®" to provide identification and secure access to information for inmates processed through the British Columbia criminal justice system.
A critical challenge that virtually every organization faces is protecting internal and customer data and making access to the systems and applications that hold that data as convenient as possible. In July 2012, IBM published a Redguide dedicated to BIO-key technology. The Redguide is the go-to resource for IBM technical support representatives and IBM resellers. IBM Redbooks and Redguide publications are developed and published by IBM. This new IBM Redguide publication is available at http://www.ibm.com/redbooks.
Mira LaCous, CTO / VP Technology and Development of BIO-key, stated, "This is my twelfth BCC event and it has been fascinating to witness the growth within the industry, along with the trend of growing acceptance for biometric technology. During the past decade plus BIO-key has developed and delivered highly accurate biometric technology solutions, as reported by the leading government testing organization NIST. We have created the benchmark for securing the biometric authentication process on any device, platform or fingerprint reader offering dynamic integration and flexibility for BIO-key customers. The BCC allows us to share our latest innovations in the area of mobile and enterprise systems as well as large scale civil AFIS solutions."
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.